Free Trial
TSE:MBX

Microbix Biosystems (MBX) Stock Price, News & Analysis

Microbix Biosystems logo
C$0.47 -0.01 (-2.08%)
As of 01:32 PM Eastern

About Microbix Biosystems Stock (TSE:MBX)

Key Stats

Today's Range
C$0.47
C$0.48
50-Day Range
C$0.36
C$0.55
52-Week Range
C$0.29
C$0.55
Volume
43,273 shs
Average Volume
216,084 shs
Market Capitalization
C$61.90 million
P/E Ratio
17.91
Dividend Yield
2.30%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products. Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada.

Receive MBX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Microbix Biosystems and its competitors with MarketBeat's FREE daily newsletter.

MBX Stock News Headlines

Microbix Presenting at Investor Conference in B.C.
Why 2026 will be a disaster for many Americans
Wall Street Legend: Why stocks are very likely to crash in Trump's 2nd Year Legendary investor Marc Chaikin says stocks could crash in 2026—he's even calling the exact month and most likely day it will start. No one on or off Wall Street has been more accurate calling the bull and bear turns of the past 7 years. And now, Chaikin is calling the crash of 2026.
Microbix Reports Strong Revenues & Earnings for Q1 Fiscal 2025
Microbix Schedules Release of Results for Q1 Fiscal 2025
See More Headlines

MBX Stock Analysis - Frequently Asked Questions

Microbix Biosystems' stock was trading at C$0.41 at the beginning of 2025. Since then, MBX shares have increased by 14.6% and is now trading at C$0.47.
View the best growth stocks for 2025 here
.

Shares of MBX stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Microbix Biosystems investors own include TransAlta Renewables (RNW), Moderna (MRNA), Canopy Growth (CGC), NightHawk Biosciences (NHWK), Organigram (OGI), VEON (VEON) and Vaxart (VXRT).

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
C$3.39 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$24.42 million
Cash Flow
C$0.11 per share
Book Value
C$0.21 per share

Miscellaneous

Free Float
N/A
Market Cap
C$61.90 million
Optionable
Not Optionable
Beta
0.34
Unlock the Potential in Options Trading Cover

Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.

Get This Free Report

This page (TSE:MBX) was last updated on 2/25/2025 by MarketBeat.com Staff
From Our Partners